Xiao Zhu1, David B Finlay2, Michelle Glass2, Stephen B Duffull1. 1. Otago Pharmacometrics Group, National School of Pharmacy, University of Otago, Dunedin, New Zealand. 2. Department of Pharmacology and Clinical Pharmacology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Abstract
BACKGROUND AND PURPOSE: Functional selectivity describes the ability of ligands to differentially regulate multiple signalling pathways when coupled to a single receptor, and the operational model is commonly used to analyse these data. Here, we assess the mathematical properties of the operational model and evaluate the outcomes of fixing parameters on model performance. EXPERIMENTAL APPROACH: The operational model was evaluated using both a mathematical identifiability analysis and simulation. KEY RESULTS: Mathematical analysis revealed that the parameters R0 and KE were not independently identifiable which can be solved by considering their ratio, τ. The ratio parameter, τ, was often imprecisely estimated when only functional assay data were available and generally only the transduction coefficient R ( τKA) could be estimated precisely. The general operational model (that includes baseline and the Hill coefficient) required either the parameters Em or KA to be fixed. The normalization process largely cancelled out the mean error of the calculated Δlog (R) caused by fixing these parameters. From this analysis, it was determined that we can avoid the need for a full agonist ligand to be included in an experiment to determine Δlog (R). CONCLUSION AND IMPLICATIONS: This analysis has provided a ready-to-use understanding of current methods for quantifying functional selectivity. It showed that current methods are generally tolerant to fixing parameters. A new method was proposed that removes the need for including a high efficacy ligand in any given experiment, which allows application to large-scale screening to identify compounds with desirable features of functional selectivity.
BACKGROUND AND PURPOSE: Functional selectivity describes the ability of ligands to differentially regulate multiple signalling pathways when coupled to a single receptor, and the operational model is commonly used to analyse these data. Here, we assess the mathematical properties of the operational model and evaluate the outcomes of fixing parameters on model performance. EXPERIMENTAL APPROACH: The operational model was evaluated using both a mathematical identifiability analysis and simulation. KEY RESULTS: Mathematical analysis revealed that the parameters R0 and KE were not independently identifiable which can be solved by considering their ratio, τ. The ratio parameter, τ, was often imprecisely estimated when only functional assay data were available and generally only the transduction coefficient R ( τKA) could be estimated precisely. The general operational model (that includes baseline and the Hill coefficient) required either the parameters Em or KA to be fixed. The normalization process largely cancelled out the mean error of the calculated Δlog (R) caused by fixing these parameters. From this analysis, it was determined that we can avoid the need for a full agonist ligand to be included in an experiment to determine Δlog (R). CONCLUSION AND IMPLICATIONS: This analysis has provided a ready-to-use understanding of current methods for quantifying functional selectivity. It showed that current methods are generally tolerant to fixing parameters. A new method was proposed that removes the need for including a high efficacy ligand in any given experiment, which allows application to large-scale screening to identify compounds with desirable features of functional selectivity.
Authors: Jonathan D Urban; William P Clarke; Mark von Zastrow; David E Nichols; Brian Kobilka; Harel Weinstein; Jonathan A Javitch; Bryan L Roth; Arthur Christopoulos; Patrick M Sexton; Keith J Miller; Michael Spedding; Richard B Mailman Journal: J Pharmacol Exp Ther Date: 2006-06-27 Impact factor: 4.030
Authors: Sudarshan Rajagopal; Seungkirl Ahn; David H Rominger; William Gowen-MacDonald; Christopher M Lam; Scott M Dewire; Jonathan D Violin; Robert J Lefkowitz Journal: Mol Pharmacol Date: 2011-05-24 Impact factor: 4.436
Authors: Caitlin R M Oyagawa; Sara M de la Harpe; Yurii Saroz; Michelle Glass; Andrea J Vernall; Natasha Lillia Grimsey Journal: Front Pharmacol Date: 2018-11-20 Impact factor: 5.810